USA flag logo/image

An Official Website of the United States Government

Nanoparticles for in vivo Oxygen Measurement in Tumors

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
75492
Program Year/Program:
2005 / SBIR
Agency Tracking Number:
CA112756
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Nomadics, Inc.
1024 S. Innovation Way Stillwater, OK 74074
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2005
Title: Nanoparticles for in vivo Oxygen Measurement in Tumors
Agency: HHS
Contract: 1R43CA112756-01
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION (provided by applicant): In an on-going collaboration with Drs. Angelo Russo and James B. Mitchell at the National Institute of Health, Nomadics has demonstrated the use of nanoparticles as fluorescence and spin contrast agents for optical and magnetic imaging simultaneously. In this project, we will develop functional imaging using near infrared (NIR) nanoparticles for oxygen measurement in tumors. Hypoxia is common in tumor and is one of, if not the, major determinant of cancer resistance to radiation therapy and chemotherapy. Likewise, the efficiency of Photodynamic Therapy is closely related to the concentration of oxygen in tumor. In addition, angiogenesis is closely correlated with oxygen distribution or gradients in tumor. Therefore, it is of great importance to interrogate tumor oxygen concentration and distribution. So far, the only commercially available sensor for oxygen detection is the polarographic needle electrode (Eppendorf(tm)) or Clark Electrode. The measurements of oxygen in tumor by Clark Electrode have provided valuable data to establish the relations between hypoxia and cancer treatment. However, there are still some obvious limitations when using Clark electrodes. Nanotechnology may offer new solutions to overcome the shortcomings of the present methods. In this project, we will demonstrate the potential for using NIR nanoparticles and oxygen intensity quenching and time-resolved decay lifetime techniques for oxygen detection. The combinations of these two techniques and the advantages of nanoparticle probes will enable the development a new oxygen sensor that can provide more accurate and more sensitive measurement of oxygen and oxygen-map imaging in vivo.

Principal Investigator:

Wei Chen
4053729535
WCHEN@NOMADICS.COM

Business Contact:


4053729535
Small Business Information at Submission:

Nomadics, Inc.
Nomadics, Inc. 1024 S Innovation Way Stillwater, OK 74074

EIN/Tax ID: 731443947
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No